Barclays Upgrades Momenta Pharmaceuticals (MNTA) to Overweight

October 11, 2016 6:50 AM EDT
Get Alerts MNTA Hot Sheet
Price: $11.65 -1.27%

Rating Summary:
    10 Buy, 2 Hold, 2 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 17 | Down: 27 | New: 7
Trade MNTA Now!
Join SI Premium – FREE

Get daily under-the-radar research with's Stealth Growth Insider Get your 2-Wk Free Trial here.

Barclays upgraded Momenta Pharmaceuticals (NASDAQ: MNTA) from Equalweight to Overweight with a price target of $19.00 (from $13.00).

For an analyst ratings summary and ratings history on Momenta Pharmaceuticals click here. For more ratings news on Momenta Pharmaceuticals click here.

Shares of Momenta Pharmaceuticals closed at $11.77 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Hot Upgrades, Upgrades

Related Entities


Add Your Comment